Cellcyte Mediserve Private Limited
About Cellcyte Mediserve Private Limited
Data last updated:
Cellcyte Mediserve Private Limited is a private limited company based in Delhi, India. It operates in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 01 March 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24100DL2012PTC232261. Its GSTIN is 07AAECC7282K1ZB (Delhi). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Munindra Kumar and Himanshu Kumar Gupta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 45 A Amar Plaza Office No. 305 Second Floor Hasanpur Main Road I.P. Extension Delh, I – 110092, Delhi, India – 110092.
As per the financials filed for FY 2024, the company reported a revenue of ₹53.34 Lakh, a decline of 12% compared to the previous year. For the same year it recorded a net profit of ₹52,456 (net margin 1%) and EBITDA of ₹2.01 Lakh (EBITDA margin 3.8%). Revenue has grown at a compounded annual rate (CAGR) of 8% over three years and 33% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Cellcyte Mediserve Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address45 A Amar Plaza Office No. 305 Second Floor Hasanpur Main Road I.P. Extension Delh, I – 110092, Delhi, India – 110092
- IndustryTrading, Wholesale, Other Wholesale
To see the full contact details of Cellcyte Mediserve Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Cellcyte Mediserve is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Cellcyte Mediserve Private Limited, buy the company report.
Financials of Cellcyte Mediserve Private Limited
FY 2025 filings availableCellcyte Mediserve Private Limited reported revenue of ₹53.34 Lakh (down 12% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 12% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 33%. EBITDA fell 24% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.01 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹52,456 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.8% | ||||
| Net Profit Margin | 1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Cellcyte Mediserve Private Limited, buy the company report.
Board of directors of Cellcyte Mediserve Private Limited
Cellcyte Mediserve has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Munindra Kumar | Director | 28 Jul 2023 | 3 Years 2 Months | Current |
| Himanshu Kumar Gupta | Director | 28 Jul 2023 | 3 Years 2 Months | Current |
Peer comparison
Cellcyte Mediserve Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Project S3 Minerals Private Limited | ₹53.36 Lakh (FY 2024) | Kakinada, Andhra Pradesh, India | ||||
| HHC Axioms Private Limited | ₹53.36 Lakh (FY 2025) | 95.0% | Belgaum, Karnataka, India | |||
| Naturacy Biotech Private Limited | ₹53.35 Lakh (FY 2025) | 6.0% | Jaipur, Rajasthan, India | |||
| Invacure Healthcare Private Limited | ₹53.34 Lakh (FY 2025) | 24.0% | Patna, Bihar, India | |||
| Kotak Lace Private Limited | ₹53.34 Lakh (FY 2025) | 18.0% | Mumbai, Maharashtra, India | |||
| Cellcyte Mediserve Private Limitedthis company | ₹53.34 Lakh (FY 2024) | ₹52,456 | 1% | -12.0% | Delhi, India | |
| Mma Design Private Limited | ₹53.33 Lakh (FY 2025) | -99.0% | Gurgaon, Haryana, India | |||
| Cast A Bridge Dental Art Private Limited | ₹53.33 Lakh (FY 2025) | -21.0% | Muzaffarpur, Bihar, India | |||
| Anumeet Technocrats (India) Private Limited | ₹53.32 Lakh (FY 2025) | -39.0% | New Delhi, Delhi, India | |||
| Nandi Traders and Entertainment Private Limited | ₹53.32 Lakh (FY 2023) | -9.0% | Mumbai, Maharashtra, India | |||
| Akp Agro Private Limited | ₹53.32 Lakh (FY 2023) | -59.0% | Chennai, Tamil Nadu, India |
To see the full peer comparison of Cellcyte Mediserve Private Limited, buy the company report.
Auditor
Cellcyte Mediserve Private Limited is audited by PRADEEPKUMARMANGLIK for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PRADEEPKUMARMANGLIK | FY 2017 | 072140 |
Shareholding
The shareholding of Cellcyte Mediserve Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Cellcyte Mediserve Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Cellcyte Mediserve Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Cellcyte Mediserve Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Cellcyte Mediserve has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAECC7282K1ZB | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Cellcyte Mediserve Private Limited, buy the company report.
Recent activity
Cellcyte Mediserve Private Limited has 7 board changes on record since 2012: 2 appointments and 5 cessations. The latest: Anupam Lata ceased to be Director on 02 Aug 2023.
Frequently asked questions
Cellcyte Mediserve is an active private limited company based in Delhi, India. The company works in wholesale, within the trading industry. It was incorporated on 01 March 2012 (14+ years old) and is registered under CIN U24100DL2012PTC232261.
Cellcyte Mediserve has 2 current directors:
- Munindra Kumar - Director
- Himanshu Kumar Gupta - Director
The latest financial statements of Cellcyte Mediserve on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Cellcyte Mediserve is 07AAECC7282K1ZB, registered in Delhi. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Cellcyte Mediserve is U24100DL2012PTC232261. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cellcyte Mediserve was incorporated on 01 March 2012, making it 14+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Cellcyte Mediserve by revenue are Project S3 Minerals Private Limited, HHC Axioms Private Limited, Naturacy Biotech Private Limited, Invacure Healthcare Private Limited, Kotak Lace Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Anupam Lata ceased to be Director on 02 Aug 2023. Ruchika Gupta ceased to be Director on 02 Aug 2023. Himanshu Kumar Gupta was appointed as Director on 28 Jul 2023. Cellcyte Mediserve has 7 board changes on record in total.
The registered office of Cellcyte Mediserve is at 45 A Amar Plaza Office No. 305 Second Floor Hasanpur Main Road I.P. Extension Delh, I – 110092, Delhi, India – 110092.
Cellcyte Mediserve operates in the trading industry, in the wholesale segment.
The compliance status of Cellcyte Mediserve is compliant as of 09 July 2026. The company is actively filing with the Registrar of Companies.